Tobacco toxicant exposure in cigarette smokers who use or do not use other tobacco products

Drug and Alcohol Dependence

Volumn 179, Issue , 2017, Pages 330-336

  Nollen, Nicole L ^a   Mayo, Matthew S ^a   Clark, Lauren ^a   Cox, Lisa Sanderson ^a   Khariwala, Samir S ^b   Pulvers, Kim ^c   Benowitz, Neal L ^d   Ahluwalia, Jasjit S ^e  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Biomarkers; Cigarettes; Non cigarette tobacco products; Tobacco toxicants

Indexed keywords

4 (METHYNITROSAMINO) 1 (3)PYRIDYLE 1 BUTANOL; CARCINOGEN; NICOTINE; NITROSAMINE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; COTININE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; EXPOSURE; FEMALE; HEALTH HAZARD; HUMAN; MALE; PRIORITY JOURNAL; SMOKING; TOBACCO USE; CHEMISTRY; ELECTRONIC CIGARETTE; METABOLISM; TOBACCO;

BIOMARKERS; CARCINOGENS; COTININE; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; NICOTINE; SMOKERS; TOBACCO PRODUCTS;

EID: 85027959128     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2017.07.021     Document Type: Article

References (55)

1. Al-Delaimy, W.K., Edland, S., Pierce, J.P., Mills, A.L., White, M., 2009 Technical Report on Analytic Methods and Approaches Used in the California Tobacco Survey Analysis. Vol 1: Data Collection Methodology., 2008, University of California, San Diego, La Jolla, CA.
2. Backinger, C.L., Fagan, P., O'Connell, M.E., Grana, R., Lawrence, D., Bishop, J.A., Gibson, J.T., Use of other tobacco products among U.S. adult cigarette smokers Prevalence, trends and correlates. Addict. Behav. 33 (2008), 472–489.
3. Benowitz, N.L., Jacob, P., Fong, I., Gupta, S., Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther. 268 (1994), 296–303.
4. Benowitz, N.L., Perez-Stable, E.J., Fong, I., Modin, G., Herrera, B., Jacob, P., Ethnic differences in N-glucuronidation of nicotine and cotinine. J. Pharmacol. Exp. Ther. 291 (1999), 1196–1203.
5. Benowitz, N., Jacob, P., Ahijevych, K., Jarvis, M., Hall, S., Hansson, A., LeHouezec, J., Lichtenstein, E., Henningfield, J.E., Tsoh, J., Hurt, R., Velicer, W., Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 4 (2002), 149–159.
6. Benowitz, N.L., Dains, K.M., Dempsey, D., Yu, L., Jacob, P., Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites. Cancer Epidemiol. Biomarkers Prev. 19 (2010), 1160–1166 (3rd).
7. Benowitz, N.L., Dains, K.M., Dempsey, D., Wilson, M., Jacob, P., Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob. Res. 13 (2011), 772–783.
8. Benowitz, N.L., Dains, K.M., Dempsey, D., Wilson, M., Jacob, P., Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure. Nicotine Tob. Res. 13 (2011), 772–783.
9. Bombard, J.M., Pederson, L.L., Nelson, D.E., Malarcher, A.M., Are smokers only using cigarettes?: Exploring current polytobacco use among an adult population. Addict. Behav. 32 (2007), 2411–2419.
10. Bombard, J.M., Pederson, L.L., Koval, J.J., O'Hegarty, M., How are lifetime polytobacco users different than current cigarette-only users?: Results from a Canadian young adult population. Addict. Behav. 34 (2009), 1069–1072.
11. Cantrell, J., Kreslake, J.M., Ganz, O., Pearson, J.L., Vallone, D., Anesetti-Rothermel, A., Xiao, H., Kirchner, T.R., Marketing little cigars and cigarillos: advertising, price, and associations with neighborhood demographics. Am. J. Public Health 103 (2013), 1902–1909.
12. Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 2012. Behavioral Risk Factor Surveillance System Survey Questionnaire. 2012, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, Georgia.
13. Chang, C.M., Edwards, S.H., Arab, A., Del Valle-Pinero, A.Y., Yang, L., Hatsukami, D.K., Biomarkers of tobacco exposure: summary of an FDA-sponsored public workshop. Cancer Epidemiol. Biomarkers Prev. 26 (2017), 291–302.
14. Chen, J., Kettermann, A., Rostron, B.L., Day, H.R., Biomarkers of exposure among U.S. cigar smokers: an analysis of 1999–2012 national health and nutrition examination survey (NHANES) data. Cancer Epidemiol. Biomarkers Prev. 23 (2014), 2906–2915.
15. Cheng, T., Chemical evaluation of electronic cigarettes. Tob. Control 23:Suppl. 2 (2014), 11–17.
16. Corey, C.G., King, B.A., Coleman, B.N., Delnevo, C., Husten, C.G., Ambrose, B.K., Apelberg, B.J., Little filtered cigar, cigarillo, and premium cigar smoking among adults − United States: 2012–2013. MMWR Morbid. Mortal. Wkly. Rep. 63 (2014), 650–654.
17. Corral, I., Landrine, H., Simms, D.A., Bess, J.J., Polytobacco use and multiple-product smoking among a random community sample of African-American adults. BMJ Open, 3, 2013, e003606.
18. Djordjevic, M.V., Doran, K.A., Nicotine content and delivery across tobacco products. Handb. Exp. Pharmacol., 2009, 61–82.
19. Dorsey, R., Graham, G., New HHS data standards for race, ethnicity, sex, primary language, and disability status. JAMA 306 (2011), 2378–2379.
20. Fagerstrom, K., Russ, C., Yu, C.R., Yunis, C., Foulds, J., The Fagerstrom Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob. Res. 14 (2012), 1467–1473.
21. Federal Trade Commission, Tar, Nicotine, and Carbon Monoxide of the Smoke of 1294 Varieties of Domestic Cigarettes for the Year 1998., 2000, Federal Trade Commission Report, Washington, D.C.
22. Federal Trade Commission, Federal Trade Commission Cigarette Report for 2011., 2012 (Washington, D.C).
23. Giovenco, D.P., Hammond, D., Corey, C.G., Ambrose, B.K., Delnevo, C.D., E-cigarette market trends in traditional U.S. retail channels, 2012–2013. Nicotine Tob. Res. 17 (2015), 1279–1283.
24. Goniewicz, M.L., Hajek, P., McRobbie, H., Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 109 (2014), 500–507.
25. Goniewicz, M.L., Knysak, J., Gawron, M., Kosmider, L., Sobczak, A., Kurek, J., Prokopowicz, A., Jablonska-Czapla, M., Rosik-Dulewska, C., Havel, C., Jacob, P., Benowitz, N., Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob. Control 23 (2014), 133–139.
26. Hecht, S.S., Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23 (2002), 907–922.
27. Hu, S.S., Neff, L., Agaku, I.T., Cox, S., Day, H.R., Holder-Hayes, E., King, B.A., Tobacco product use among adults − United States, 2013–2014. MMWR Morb. Mortal. Wkly. Rep. 65 (2016), 685–691.
28. Jacob, P., Havel, C., Lee, D.H., Yu, L., Eisner, M.D., Benowitz, N.L., Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal. Chem 80 (2008), 8115–8121.
29. Jamal, A., King, B.A., Neff, L.J., Whitmill, J., Babb, S.D., Graffunder, C.M., Current cigarette smoking among adults − United States, 2005–2015. MMWR Morb. Mortal. Wkly. Rep. 65 (2016), 1205–1211.
30. Janbaz, K.H., Qadir, M.I., Basser, H.T., Bokhari, T.H., Ahmad, B., Risk for oral cancer from smokeless tobacco. Contemp. Oncol. (Pozn.) 18 (2014), 160–164.
31. Jolly, D.H., Exploring the use of little cigars by students at a historically black university. Prev. Chronic Dis., 5, 2008, A82.
32. Kasza, K.A., Bansal-Travers, M., O'Connor, R.J., Compton, W.M., Kettermann, A., Borek, N., Fong, G.T., Cummings, K.M., Hyland, A.J., Cigarette smokers' use of unconventional tobacco products and associations with quitting activity: findings from the ITC-4U.S. cohort. Nicotine Tob. Res. 16 (2014), 672–681.
33. Kasza, K.A., Ambrose, B.K., Conway, K.P., Borek, N., Taylor, K., Goniewicz, M.L., Cummings, K.M., Sharma, E., Pearson, J.L., Green, V.R., Kaufman, A.R., Bansal-Travers, M., Travers, M.J., Kwan, J., Tworek, C., Cheng, Y.C., Yang, L., Pharris-Ciurej, N., van Bemmel, D.M., Backinger, C.L., Compton, W.M., Hyland, A.J., Tobacco-product use by adults and youths in the United States in 2013 and 2014. N. Engl. J. Med. 376 (2017), 342–353.
34. Khariwala, S.S., Scheuermann, T.S., Berg, C.J., Hayes, R.B., Nollen, N.L., Thomas, J.L., Guo, H., Ahluwalia, J.S., Benowitz, N.L., Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample. Nicotine Tob. Res. 16 (2014), 600–605.
35. Lee, Y.O., Hebert, C.J., Nonnemaker, J.M., Kim, A.E., Multiple tobacco product use among adults in the United States Cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus. Prev. Med. 62 (2014), 14–19.
36. McRobbie, H., Phillips, A., Goniewicz, M.L., Smith, K.M., Knight-West, O., Przulj, D., Hajek, P., Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine carbon monoxide, and acrolein. Cancer Prev. Res. (Phila.) 8 (2015), 873–878.
37. National Cancer Institute, Smoking and tobacco control monograph 9: cigars: health effects and trends. Nat. Cancer Institute Bethesda MD, 1998.
38. Nollen, N.L., Ahluwalia, J.S., Lei, Y., Yu, Q., Scheuermann, T.S., Mayo, M.S., Adult cigarette smokers at highest risk for concurrent alternative tobacco product use among a racially/ethnically and socioeconomically diverse sample. Nicotine Tob. Res. 18 (2015), 386–394.
39. Nollen, N.L., Cox, L.S., Yu, Q., Ellerbeck, E.F., Scheuermann, T.S., Benowitz, N.L., Tyndale, R.F., Mayo, M.S., Ahluwalia, J.S., A clinical trial to examine disparities in quitting between African-American and White adult smokers: design, accrual, and baseline characteristics. Contemp. Clin. Trials 47 (2016), 12–21.
40. Nonnemaker, J., Rostron, B., Hall, P., MacMonegle, A., Apelberg, B., Mortality and economic costs from regular cigar use in the United States, 2010. Am. J. Public Health 104 (2014), e86–91.
41. Page, J.B., Evans, S., Cigars, cigarillos, and youth: emergent patterns in subcultural complexes. J. Ethn. Subst. Abuse 2 (2004), 63–76.
42. Primack, B.A., Carroll, M.V., Weiss, P.M., Shihadeh, A.L., Shensa, A., Farley, S.T., Fine, M.J., Eissenberg, T., Nayak, S., Systematic review and meta-analysis of inhaled toxicants from waterpipe and cigarette smoking. Public Health Rep. 131 (2016), 76–85.
43. Richardson, A., Xiao, H., Vallone, D.M., Primary and dual users of cigars and cigarettes Profiles, tobacco use patterns and relevance to policy. Nicotine Tob. Res. 14 (2012), 927–932.
44. Rostron, B.L., Chang, C.M., van Bemmel, D.M., Xia, Y., Blount, B.C., Nicotine and toxicant exposure among U.S. smokeless tobacco users: results from 1999 to 2012 national health and nutrition examination survey data. Cancer Epidemiol. Biomarkers Prev. 24 (2015), 1829–1837.
45. Shiffman, S., Dunbar, M.S., Benowitz, N.L., A comparison of nicotine biomarkers and smoking patterns in daily and nondaily smokers. Cancer Epidemiol. Biomarkers Prev. 23 (2014), 1264–1272.
46. Shihadeh, A., Schubert, J., Klaiany, J., El Sabban, M., Luch, A., Saliba, N.A., Toxicant content, physical properties and biological activity of waterpipe tobacco smoke and its tobacco-free alternatives. Tob. Control 24 (2015), i22–i30.
47. Singh, T., Arrazola, R.A., Corey, C.G., Husten, C.G., Neff, L.J., Homa, D.M., King, B.A., Tobacco use among middle and high school students-United States, 2011-2015. MMWR Morb. Mortal. Wkly. Rep. 65 (2016), 361–367.
48. St Helen, G., Dempsey, D., Wilson, M., Jacob, P., Benowitz, N.L., Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure. Addiction 108 (2013), 607–617.
49. Timofeeva, M.N., McKay, J.D., Smith, G.D., Johansson, M., Byrnes, G.B., Chabrier, A., Relton, C., Ueland, P.M., Vollset, S.E., Midttun, O., Nygard, O., Slimani, N., Romieu, I., Clavel-Chapelon, F., Boutron-Ruault, M.C., Fagherazzi, G., Kaaks, R., Teucher, B., Boeing, H., Weikert, C., Bueno-de-Mesquita, H.B., van Gils, C., Peeters, P.H., Agudo, A., Barricarte, A., Huerta, J.M., Rodriguez, L., Sanchez, M.J., Larranaga, N., Khaw, K.T., Wareham, N., Allen, N.E., Travis, R.C., Gallo, V., Norat, T., Krogh, V., Masala, G., Panico, S., Sacerdote, C., Tumino, R., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Rasmuson, T., Hallmans, G., Riboli, E., Vineis, P., Brennan, P., Genetic polymorphisms in 15q25 and 19q13 loci cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiol. Biomarkers Prev. 20 (2011), 2250–2261.
50. U.S. Department of Health and Human Services, The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General. U.S., 2014, Department of Health and Human Services, CDC, Atlanta, GA.
51. Yuan, J.M., Koh, W.P., Murphy, S.E., Fan, Y., Wang, R., Carmella, S.G., Han, S., Wickham, K., Gao, Y.T., Yu, M.C., Hecht, S.S., Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res. 69 (2009), 2990–2995.
52. Yuan, J.M., Gao, Y.T., Murphy, S.E., Carmella, S.G., Wang, R., Zhong, Y., Moy, K.A., Davis, A.B., Tao, L., Chen, M., Han, S., Nelson, H.H., Yu, M.C., Hecht, S.S., Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Res. 71 (2011), 6749–6757.
53. Yuan, J.M., Butler, L.M., Stepanov, I., Hecht, S.S., Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer Res. 74 (2014), 401–411.
54. Zhou, S., Van Devanter, N., Fenstermaker, M., Cawkwell, P., Sherman, S., Weitzman, M., A study of the use, knowledge, and beliefs about cigarettes and alternative tobacco products among students at one U. S. medical school. Acad. Med. 90 (2015), 1713–1719.
55. Zhu, A.Z., Renner, C.C., Hatsukami, D.K., Swan, G.E., Lerman, C., Benowitz, N.L., Tyndale, R.F., The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6 The influence of genetics, race, and sex. Cancer Epidemiol. Biomarkers Prev. 22 (2013), 708–718.